期刊文献+

ALK抑制剂克唑替尼的专利分析 被引量:3

Patent analysis for ALK inhibitor crizotinib
原文传递
导出
摘要 本文利用incopat科技情报创新平台,对ALK抑制剂克唑替尼的全球申请进行了检索筛选,通过数据处理及加工,对该药物的专利申请趋势、技术发展的生命周期、主要申请人、专利技术构成以及法律状态进行了分析,并针对该药原研公司布局的中国专利情况做了进一步分析,有利于指导国内制药企业进行项目立项、专利布局,并在此基础上开展仿创性的新药研发工作。 By means of the technology innovation information service platform of incopat,the global patents of ALK inhibitor crizotinib were retrieved. After processing the data for crizotinib related patents,such as patent application trends,technological development life cycle,the principal applicant,the composition of patent technology and patent legal status are analyzed,the patent information of crizotinib from Pfizer was analyzed and researched and we especially dissect its layout to the patent situation in China. This article can be beneficial to guide the domestic pharmaceutical enterprises on the project establishment,patent layout,and to carry out the generics and new drug RD works on this basis.
出处 《中国新药杂志》 CAS CSCD 北大核心 2017年第5期484-488,共5页 Chinese Journal of New Drugs
关键词 克唑替尼 专利检索 专利信息分析 专利布局 crizotinib patent retrieve patent information analysis patent layout
  • 相关文献

参考文献2

二级参考文献50

  • 1黄璐,李威,耿海明.干眼症药物专利信息分析[J].食品与药品,2011,13(5):198-200. 被引量:5
  • 2JEMAL A, BRAY F, CENTER MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 3HOWLADER N, NOONE A, KRAPCHO M, et al. SEER Cancer Statistics Review 1975-2010[EB/OL]. Bethesda, MD: National Cancer Institute; 2010. [2013-06-06].http://seer.cancer.gov/csr/1975_2010/.
  • 4BARNHOLTZ-SLOAN JS, SLOAN AE, DAVIS FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System[J]. J Clin Oncol, 2004, 22(14): 2865-2872.
  • 5SCHOUTEN LJ, RUTTEN J, HUVENEERS HA, et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma[J]. Cancer, 2002, 94(10): 2698-2705.
  • 6HUBBS JL, BOYD JA, HOLLIS D, et al. Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer[J]. Cancer, 2010, 116(21): 5038-5046.
  • 7TABOURET E, CHINOT O, METELLUS P, et al. Recent trends in epidemiology of brain metastases: an overview[J]. Anticancer Res, 2012, 32(11): 4655-4562.
  • 8SMEDBY KE, BRANDT L, BCKLUND ML, et al. Brain metastases admissions in Sweden between 1987 and 2006[J]. Br J Cancer, 2009, 101(11): 1919-1924.
  • 9KOIVUNEN JP, MERMEL C, ZEJNULLAHU K, et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer[J]. Clin Cancer Res, 2008, 14(13): 4275-4283.
  • 10SODA M, CHOI YL, ENOMOTO M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer[J]. Nature, 2007, 448(7153): 561-566.

共引文献20

同被引文献26

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部